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Abstract  1 
Purpose: Childhood cancers are rare and little is known about their aetiology. Potential risk factors 2 
include environmental exposures that might implicate spatial variation of cancer risk. Previous studies 3 
of spatial clustering have mainly focused on childhood leukaemia. We investigated spatial clustering 4 
of different childhood cancers in Switzerland using exact geocodes of place of residence.  5 
Methods: We included 6,034 cancer cases diagnosed at age 0-15 years during 1985-2015 from the 6 
Swiss Childhood Cancer Registry. Age and sex matched controls (10 per case) were randomly 7 
sampled from the national censuses (1990, 2000, 2010). Geocodes of place of residence were available 8 
at birth and diagnosis for both cases and controls. We used the difference in k-functions and Cuzick-9 
Edwards’ test to assess global clustering and Kulldorff’s circular scan to detect individual clusters. We 10 
also carefully adjusted for multiple testing.  11 
Results: After adjusting for multiple testing, we found no evidence of spatial clustering of childhood 12 
cancers neither at birth (p = 0.43) nor diagnosis (p = 0.13). Disregarding multiple testing, results of 13 
individual tests indicated spatial clustering of all childhood cancers combined (p < 0.01), childhood 14 
lymphoma (p = 0.01), due to Hodgkin lymphoma (p = 0.02) at diagnosis, and embryonal tumours of 15 
the central nervous system (CNS) at birth and diagnosis, respectively (p = 0.05 and p = 0.02).  16 
Conclusions: This study provides weak evidence of spatial clustering of childhood cancers. Evidence 17 
was strongest for Hodgkin lymphoma and embryonal CNS tumours, adding to the current literature 18 
that these cancers cluster in space. 19 
 20 
 21 
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Introduction 1 
Childhood cancers are rare and little is known about possible environmental risk factors. For 2 
leukaemia and central nervous system (CNS) tumours, the two most common cancer types in 3 
childhood, ionising radiation in high doses is the only established environmental risk factor [1-3]. 4 
Infection with Epstein-Barr is thought to play a role in the aetiology of Burkitt’s lymphoma (BL) and 5 
Hodgkin lymphoma (HL) [4]. A number of other environmental exposures are suspected of causing 6 
cancer in children including low-dose ionising radiation (e.g. natural background radiation or 7 
diagnostic radiology) [3], benzene [5,6], traffic-related air pollution [7] and pesticides [8,9], However, 8 
despite numerous epidemiological studies no firm conclusions regarding a causative role of these 9 
factors can yet be drawn.  10 
Spatial variation of exposure to environmental factors may result in local aggregations of cancer cases. 11 
Such spatial aggregation might appear as distinct local clusters or as a general tendency of cases to 12 
occur closer to each other than would be expected if cases were homogenously distributed across the 13 
population (global clustering). Detecting spatial clustering or individual clusters could thus provide 14 
hints about underlying risk factors. Furthermore, the timing of spatial clustering might provide clues 15 
about age windows of susceptibility and latent periods. If the causative exposure occurs in utero or in 16 
early life, clustering would more likely be detected around time of birth (using address at birth). If on 17 
the other hand, the relevant exposure is closer to the time of diagnosis and latent periods are short, 18 
clustering would more likely be detected around the time of diagnosis (using address at diagnosis). 19 
Moreover, while aetiologies, and thus clustering patterns, are likely to differ between diagnostic 20 
groups, some carcinogens such as ionising radiation may increase the risk of multiple cancer types. It 21 
is thus also of interest to investigate spatial clustering of the combined group of all childhood cancers 22 
in addition to individual diagnostic groups. 23 
More than 50 studies have investigated spatial clustering of childhood cancers, the majority of which 24 
focused on childhood leukaemia [10,11], including a previous study by the authors [12]. Fewer studies 25 
have investigated spatial clustering of other childhood cancers and these have focused on place of 26 
diagnosis, except for two studies that investigated residential locations at birth [13,14]. A study from 27 
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the UK reported evidence of spatial clustering of all cancers combined [15]. Based on cluster detection 1 
methods, childhood cancer clusters (all diagnostic groups combined) have been reported in Florida, 2 
Palestine and Canada [16-18]. Studies from San Francisco and the UK have reported evidence of 3 
spatial clustering of HL, both supporting an association with Epstein-Barr virus (EBV) through 4 
correlation with deprivation [19,20], whereas a study in Spain reported clustering of HL and non-5 
Hodgkin lymphoma (NHL) in certain regions [21]. A study in Kenya reported spatial clustering of BL 6 
[22], further supporting the already established infectious aetiology [23]. The aforementioned study 7 
from Palestine reported a cluster of childhood lymphoma [17]. The majority of studies investigating 8 
CNS tumours have not found evidence of spatial clustering [24,25,15,26,21], however, only few 9 
studies have investigated specific subtypes of CNS tumours. Evidence of spatial clustering was 10 
previously reported for medulloblastoma [24,26]. 11 
Several methodological shortcomings limit the interpretability of these studies. Often only count data 12 
aggregated to administrative areal units (e.g. census tracts) were available, reducing the statistical 13 
power to detect clustering [27-29]. Results of spatial analyses using regional count data may vary 14 
considerably depending on the areal unit selected (modifiable areal unit problem) [30]. To our 15 
knowledge only one study has used precise geocodes [21]. Furthermore, most studies performed 16 
different statistical tests for different diagnostic or age groups without adjusting for the multiple tests 17 
performed [15,18]. 18 
Following our previous analysis of spatial clustering of childhood leukaemia [12], we aimed to 19 
investigate the spatial distribution of other childhood cancers in Switzerland including lymphomas, 20 
HL, NHL, CNS tumours, astrocytoma, intracranial and intraspinal embryonal tumours, other CNS 21 
tumours, neuroblastoma, nephroblastoma, malignant bone tumours and soft tissue sarcomas. We also 22 
examined the combined group of all childhood cancers. We investigated spatial clustering at birth and 23 
diagnosis using geocoded places of residence, paying particular attention to appropriate correction for 24 
multiple testing.  25 
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Methods 1 
Population 2 
We included childhood cancer cases diagnosed at age 0-15 years in Switzerland during 1985-2015 3 
from the Swiss Childhood Cancer Registry (SCCR). The SCCR is a national population-based cancer 4 
registry for children and adolescents in Switzerland with an estimated completeness of 91% since 5 
1985 and 95% since 1995 [31]. The SCCR tracks residential address histories from diagnosis back to 6 
birth by contacting municipal population registers. Geocodes were obtained using the geo-referenced 7 
building addresses from the Swiss postal system (Geopost) or manually localising the buildings on the 8 
geoportal of the Federal Office of Topography (swisstopo; http://map.geo.admin.ch). For 9 
approximately 94% of the cases, we could geocode residential addresses with a margin of error <100 10 
m. For the remaining 6% we used a midpoint of the street, when the street name was available or a 11 
central residential location within the postal code area when only the postal code was known. Lastly, 12 
in order to avoid any influence of familial aggregation due to genetic factors, we included only one 13 
case from pairs of sibling cases.  14 
Data for the population at risk were available from the Swiss National Cohort study [32] which 15 
includes the Swiss resident population at time of previous decennial questionnaire-based national 16 
censuses (1990, 2000) and the annual register-based censuses beginning in 2010. The data include 17 
geocoded place of residence at the time of censuses. Using a two-step weighted sampling procedure 18 
described in detail previously [33], we sampled 10 controls per case from this dataset matching on sex 19 
and timing of clustering. Thus for analyses of clustering at birth, we selected children aged <1 year 20 
from the censuses closest in time to a case’s birth, and for clustering at diagnosis we selected children 21 
matched for age at diagnosis from the censuses closest in time to a case’s diagnosis. The sampling 22 
procedure adjusts for regional population shifts between decennial censuses at the municipal level 23 
[33]. 24 
Outcomes 25 
The SCCR codes diagnoses according to the International Classification of Childhood Cancer, third 26 
edition [34]. We investigated the following diagnostic groups: all cancers combined (groups I-XII), 27 
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childhood lymphoma (II), HL (IIa), NHL (IIb, IIc, IId, IIe ), CNS tumours (III), astrocytoma (IIIb), 1 
intracranial and intraspinal embryonal tumours (IIIc, here referred to as embryonal CNS tumours), 2 
other CNS tumours (IIIa, IIId, IIIe, IIIf), neuroblastoma (IV), nephroblastoma (VIa), malignant bone 3 
tumours (VIII) and soft tissues sarcomas (IX). These outcomes were chosen because the number of 4 
cases available at diagnosis exceeded the arbitrary threshold of 250 cases. 5 
Statistical Analysis 6 
We used difference in k-functions [35] and Cuzick-Edwards’ test [36] to assess global clustering and 7 
Kulldorff’s circular scan to detect local clusters [37]. Global clustering tests assess the preponderance 8 
of other cases over controls in the proximity of cases using different distance metrics: Euclidean 9 
distance (d) for difference in k-functions and the number of nearest neighbours (NN) for Cuzick-10 
Edwards’ test. We selected a wide range of values for d (100, 250, 450, 600, 1000, 1500, 2000, 3000, 11 
4000 and 5000 m) and corresponding values of NN based on the expected number of nearest 12 
neighbours within these distances given the number of cases and controls of each diagnostic group 13 
(see Supplementary Table S1). For Kulldorff’s circular scan, the upper limit for the radii was set such 14 
that the resulting circles included half of the total number of case and control locations. The tests and 15 
their implementation are described in more detail elsewhere [12]. 16 
As in our previous investigation of childhood leukaemia [12], we used Monte Carlo simulation to 17 
calculate p-values for the tests (Supplementary Text S1) and to adjust for multiple testing at three 18 
levels (Supplementary Text S2). At a first level of adjustment, we calculated test-statistics that 19 
accounted for the multiple input values used in each test, namely, the standardised maximum 20 
difference for k-functions [35], the minimum profile p-value in Cuzick-Edwards’ test [36], and the 21 
maximum likelihood ratio for Kulldorff’s circular scan [37]. We then generated 999 Monte Carlo 22 
samples by randomly permuting case and control labels given the locations, calculating the same 23 
statistics for each sample. We then calculated p-values for the test-statistics by ranking the empirical 24 
value of the test statistic among the corresponding values of the Monte Carlo samples and dividing the 25 
obtained rank by 1000. Finally, we calculated the minimum of the p-values from the first level 26 
adjustment over the three statistical tests performed for each diagnostic subgroup (second level 27 
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adjustment) and minimum over all statistical tests and diagnostic groups (third level adjustment) again 1 
obtaining p-values by ranking these among corresponding values form the 999 Monte Carlo samples 2 
(see Supplementary Text S2 for more details). This correction for multiple testing is less conservative 3 
than a Bonferroni adjustment because it accounts for correlations between tests.  4 
For residence at diagnosis, we ran a sensitivity analysis excluding the less precise geocodes (margin of 5 
error > 100 m).  6 
Results 7 
 8 
Study Population 9 
We identified 6,057 eligible cases of childhood cancer in the SCCR (Fig. 1). After excluding cases 10 
with missing geocodes and one record of each sibling pair, we included 6,034 cases for the analysis of 11 
spatial clustering at diagnosis. For the analysis at birth, we additionally excluded those born abroad or 12 
with uncertain place of birth and those born before 1985, leaving 4,078 cases available for analysis 13 
(Fig. 1). The age and sex distribution of included cancer cases follows the general pattern seen for 14 
different diagnostic groups in the SCCR and registries of neighbouring countries (Table 1) [38,39]. 15 
Clustering results 16 
After adjusting for all tests performed (third level adjustment), we found no evidence of global 17 
clustering or local clusters neither at birth (overall p = 0.43) nor diagnosis (overall p = 0.13) (Table 2). 18 
However, at the second level of adjustment, i.e. ignoring the fact that multiple diagnostic groups were 19 
investigated, our results were indicative of global clustering or clusters for the group of all cancers 20 
combined (p = 0.01) and childhood lymphoma (p = 0.04) at diagnosis and for embryonal CNS tumours 21 
at birth (p = 0.05) and diagnosis (p = 0.02). The evidence for lymphoma was stronger for HL (p = 22 
0.06) than for NHL (p = 0.43).  23 
In the analysis of all childhood cancers at diagnosis, the strongest evidence was obtained from k-24 
functions at 4 km distances (adjusted p <0.01, Table 2). Fig. 2 shows that the evidence of clustering 25 
was strongest for distances larger than 500 m (top-left plot). The shaded area shows the typical range 26 
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of values of the difference in k-functions in the absence of clustering (95% simulation envelopes under 1 
Monte Carlo sampling). 2 
In the analysis of childhood lymphoma, the strongest evidence for global clustering at diagnosis was 3 
observed for difference in k-functions at 3,000 m (adjusted p = 0.01, Table 2). The top-right plot in 4 
Fig. 2 indicates clustering for distances larger than 1,500 m. Strong evidence from the difference in k-5 
functions was also observed for HL at a similar spatial scale (adjusted p = 0.02 at 3,000 m) but not for 6 
the NHL (adjusted p = 0.28 at 600 m) (Table 2; bottom plots in Fig. 2).  7 
The strongest evidence for global clustering of embryonal CNS tumours was observed using Cuzick-8 
Edwards’ test at diagnosis using 2 NN (adjusted p = 0.01) (Table 2), corresponding to distances of up 9 
to 1,400 m on average (Supplementary Table S1). The expected number of other cases among the 2 10 
NN of a case was 47.79, whereas we observed 73 cases (Supplementary Table S2). Kulldorff’s 11 
circular scan showed evidence of a cluster of embryonal CNS tumours at birth (adjusted p = 0.02, 12 
radius = 66,400 m) (Fig. 3). The cluster consisted of 66 cases, while the number of cases expected 13 
within this circle was 39.2, yielding a relative risk of 2.1. Weaker evidence was observed at diagnosis 14 
(adjusted p = 0.05, radius = 17,400 m) indicating a smaller cluster, nested in the above cluster (Fig. 3). 15 
The number of cases in this circle was 23 while 8.4 were expected, resulting a relative risk of 2.9. 16 
When we considered only first level corrections for multiple testing (i.e. correcting only for the 17 
different input values) our results were also indicative of global clustering of neuroblastoma (k-18 
functions adjusted p = 0.08, at 5,000 m, Supplementary Fig. S1), and a cluster of nephroblastoma at 19 
diagnosis. This cluster consisted of 13 cases in a circle of almost 14 km. Based on Monte Carlo 20 
samples the expected number of cases on that circle was 3.18.  21 
Sensitivity analysis 22 
When we excluded 361 geocodes with a margin of error >100 m at diagnosis, p-values tended to be 23 
lower. The overall evidence was strong (overall p = 0.03, Supplementary Table S3). In particular, 24 
stronger evidence of spatial clustering was found for all cancers (2nd level adjusted p <0.01), childhood 25 
lymphoma (2nd level adjusted p = 0.02), HL (2nd level adjusted p = 0.05) and embryonal CNS tumours 26 
(2nd level adjusted p = 0.03) (Supplementary Table S3). For the group of all cancers Kulldorff’s scan 27 
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statistic identified a cluster in the north-east of Switzerland (adjusted p = 0.01, radius = 23,199 m, 1 
Supplementary Table S3; Supplementary Fig. S4). 2 
Post hoc analyses 3 
In a post hoc analysis, we investigated the difference in k-functions for childhood lymphoma at 4 
diagnosis for distances up to 30 km, rather than up to 5 km only as in the main analysis. We observed 5 
evidence of clustering for distances up to 7 km (Supplementary Fig. S2).  6 
We also investigated whether the clustering of lymphoma, embryonal CNS tumours and 7 
neuroblastoma (based on the difference in k-functions results) accounted for the observed clustering of 8 
all cancers at diagnosis. We thus performed the difference in k-functions for the all cancers group 9 
excluding these diagnostic groups and observed no evidence of clustering (p k-functions = 0.16 at 5 10 
km), (Supplementary Fig. S3).  11 
Discussion 12 
Summary of the results 13 
This nationwide study investigated spatial clustering of childhood cancers in Switzerland during 1985-14 
2015 using precise locations of residence. After correcting for the multiple testing resulting from 15 
investigating different diagnostic groups, we found no evidence of spatial clustering or of individual 16 
clusters, neither at birth nor at diagnosis. However, when considering diagnostic groups separately, we 17 
found evidence of clustering for the group of all cancers combined and for lymphoma at diagnosis, 18 
and for embryonal CNS tumours at birth and diagnosis. The evidence was stronger for HL than for 19 
NHL. The difference in k-functions suggested excesses of cases occurring near other cases for 20 
distances of 2-5 km for HL and 500 m to 3 km for embryonal CNS tumours. Kulldorff’s circular scan 21 
identified a cluster of cases with embryonal CNS tumours in the north-west of Switzerland at birth 22 
(radius 66 km) and at diagnosis (radius 17 km). The evidence of clustering for the group of all cancers 23 
disappeared when lymphoma, embryonal CNS tumours and neuroblastoma were excluded. 24 
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Discussion in the context of other studies 1 
To our knowledge, a recent analysis of five regions in Spain is the only other study of spatial 2 
clustering of childhood cancers other than leukaemia using precise geocodes of residence [21]. That 3 
study included 714 CNS tumours, 92 HL and 246 NHL cases and 6 matched controls per case. The 4 
difference in k-function showed evidence of clustering for both HL and NHL in some regions, but not 5 
for CNS tumours. Kulldorff’s circular scan found little evidence of spatial clusters, with the lowest p-6 
value (0.074) observed for a small aggregation of NHL cases in Madrid. 7 
Few studies have applied global clustering tests or cluster detection methods to the group of all 8 
cancers combined. A large study from the UK including over 30,000 childhood cancer cases 9 
aggregated to census wards found evidence of clustering at diagnosis, which remained significant after 10 
excluding cases of lymphoma and leukaemia.[15,40] Evidence for local clusters of all cancers 11 
combined has been reported in studies from Florida [16], Palestine [17] and Canada [18]. The only 12 
other study that examined clustering of all cancers combined at birth was a study from the UK, which 13 
also found no evidence of clustering in agreement with our study [13]. 14 
The majority of studies investigating lymphoma as a group reported weak evidence of spatial 15 
clustering at diagnosis [16,15,21,25]. One study reported evidence of a cluster of childhood lymphoma 16 
in Palestine [17], yet 53% of the included cases were Burkitt’s lymphoma. This result is not surprising 17 
since the geographical patterns of Burkitt’s lymphoma and its infectious aetiology are known [41,22]. 18 
In agreement with our study, other studies have also reported spatial clustering of HL at diagnosis 19 
[42,20,19,21] – whereas, evidence from the mentioned, large UK study was weak [15]. A study in 20 
New Zealand found no evidence of global clustering of HL at birth [14]. Studies examining NHL have 21 
consistently reported no evidence of clustering [19,15,14]. 22 
Previous studies of spatial clustering of CNS tumours in children have, at most, found only weak 23 
evidence of global clustering or clusters [24,43,26,25,21]. In two studies that also examined major 24 
histologic subgroups, evidence of clustering was found for medulloblastoma [24] and the combined 25 
group of primitive neuroectodermal tumour (PNET) and medulloblastomas [26]. In our study PNET 26 
and medulloblastomas are the main tumour types subsumed as embryonal CNS tumours, for which we 27 
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also found evidence of clustering. No evidence of spatial clustering has been reported for other CNS 1 
tumour types [24,43,26]. 2 
Few studies have assessed spatial clustering of other cancer diagnostic groups. Evidence for clustering 3 
was found in the UK for soft tissue sarcomas and Wilm’s tumours [15]. Studies investigating bone 4 
tumours separately or jointly with soft tissue sarcomas have reported weak evidence of clustering 5 
[15,25]. 6 
Strengths and Weaknesses 7 
The main strength of our study is the use of precise locations of residence for both cases and 8 
representative controls. This avoids the modifiable areal unit problem and maximises statistical power 9 
for detecting small scale clustering [28,30]. Cancer cases were obtained from a national registry with 10 
high coverage, and we were able to examine residence both at birth and at diagnosis. The use of 11 
different statistical tests made our analysis sensitive to different clustering patterns. Cuzick-Edwards’ 12 
test and the difference in k-functions are both sensitive to an overall tendency of cases to occur closer 13 
to each other than expected but use different proximity metrics (NN and Euclidean distance 14 
respectively). Kulldorff’s circular scan on the other hand is more sensitive to the presence of distinct 15 
clusters. We paid considerable attention to the multiple testing problem. In a previous analysis of 16 
childhood leukaemia, we also included Tango’s index as an additional test of global clustering but 17 
found that it was highly correlated with the difference in k-functions (see the electronic supplementary 18 
material of our previous analysis [12]). We therefore decided not to use Tango’s index for this analysis 19 
in order to mitigate the multiple testing problem. Lastly, we implemented a multiple testing approach 20 
that accounts for the correlation between tests and is less conservative than a Bonferroni approach.  21 
While full address histories were known for cases, location of residence of controls was only available 22 
at census time points. We could thus not select control locations that were perfectly representative of 23 
the population at risk at cases’ exact date of birth or diagnosis. However, we used a control sampling 24 
procedure that accounted for local population shifts in the years between the censuses. In order to 25 
minimise the multiple testing issue, we only used one cluster detection test, namely Kulldorff’s 26 
circular scan, which is the most widely used scan statistic. A drawback of this scan statistic is that it 27 
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only considers circular shapes and may thus have been insensitive to possible clusters of irregular 1 
shapes or clusters occurring at the country border and extending into the neighbouring country, for 2 
which we had no data. Moreover, despite high completeness of the registry, our analyses missed a 3 
small proportion of cases, which may have reduced the statistical power of clustering tests. Lastly, 4 
geographical disparities in registration coverage may have affected our results. While the vast majority 5 
of childhood cancer cases are registered through specialised paediatric oncology centres, a small 6 
minority is identified through general cantonal cancer registries. However, not all cantons have a 7 
general cancer registry possibly leading to underreporting in these cantons. Kulldorff’s scan compares 8 
the risk inside and outside defined circles. If there was systematic underreporting of cancer cases 9 
outside of certain circles, this could have led to spurious clusters. This is unlikely to have been the 10 
case for the clusters of embryonal CNS tumours identified in our analysis since the proportion of cases 11 
identified through cantonal registries was lower inside the clusters than outside: 0.02 against 0.06 for 12 
the cluster at birth and 0.05 against 0.07 for the cluster at diagnosis. In contrast this might be a 13 
possible explanation for the cluster of all cancers reported in the sensitivity analysis (proportion of 14 
cases from cantonal registry 0.14 inside the circle against 0.05 outside). 15 
Interpretation of findings 16 
The fact that no evidence of spatial clustering for the combined group of all cancers remained when 17 
cases of lymphoma, embryonal CNS tumours and neuroblastoma were excluded suggests that any 18 
spatial clustering of childhood cancers in Switzerland during the study period was mainly driven by 19 
these subgroups. 20 
The clustering observed for lymphoma appears to be driven by HL. Spatial clustering of HL at 21 
diagnosis is consistent with the literature with 4 out of 6 studies reporting such evidence. The absence 22 
of distinct clusters and of clustering at birth may imply a late aetiologic exposure to a ubiquitous agent 23 
promoting carcinogenesis [20]. Animal and epidemiological studies suggest that exposure to EBV 24 
could be such a promotor [4]. Possible socioeconomic factors associated with transmission of EBV or 25 
prevalence of EBV infection such as overcrowding [4] might cause spatial heterogeneity in incidence 26 
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rates of HL. Other agents such as benzene might also play a role. However, there is little evidence of 1 
an association between HL and occupational benzene exposure in adults [44]. 2 
Our finding of global clustering of embryonal CNS tumours but not for other CNS tumours is also in 3 
agreement with the two other studies that have assessed medulloblastoma or PNET [24,26] and 4 
suggests an aetiologic factor specific to this tumour group. Of the 264 embryonal CNS tumour cases 5 
included in our study, 198 and 46 were medulloblastomas and PNET, respectively. The evidence of 6 
clustering was stronger at diagnosis, again suggesting a late aetiologic exposure. Unfortunately, 7 
aetiologic studies of childhood CNS tumours still rarely distinguish histologic subtypes. However, 8 
based on this literature, possible aetiological agents include insecticide use [45], N-nitroso compounds 9 
exposure [46] or traffic-related air pollution [47]. 10 
While adjustments for multiple testing indicate that our findings could be due to chance, the agreement 11 
with previous studies regarding HL and embryonal CNS tumours rather suggests that the observed 12 
clustering may have an environmental or infectious cause. 13 
Conclusion 14 
Our study adds further evidence that HL and embryonal CNS tumours in children tend to cluster in 15 
space due to post-natal environmental influences, which remain to be determined. Future aetiological 16 
studies of childhood lymphoma and CNS tumours should stratify analyses by tumour subtypes and 17 
pool data to maximise power. 18 
 19 
 20 
 21 
 22 
 23 
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Tables 1 
Table 1. Characteristics of the cases included in the analysis of spatial clustering using residence at 2 
birth and at diagnosis. 3 
 4 
 5 
 6 
a
 Includes childhood leukaemia cases (N= 1,297 and 1,865 for birth and diagnosis, respectively) which 7 
were the subject of a separate investigation [12]. 8 
 9 
 10 
 11 
Birth Diagnosis 
 Number of cases Age at 
diagnosis 
Number of cases 
 
Age at 
diagnosis 
 
Total Female N (%) Median Total Female N (%) Median 
All cancersa 4,078 1,826 (44.8) 4.6 6,034 2,694 (44.6) 6.3 
Lymphoma 419 144 (34.4) 10.1 760 275 (36.2) 11.5 
    HL 165 71 (43.0) 13.3 317 149 (47.0) 13.7 
    NHL 253 74 (29.2) 6.9 441 127 (28.8) 8.8 
CNS tumours 840 390 (46.4) 5.8 1,240 575 (46.4) 7.0 
    Astrocytoma 340 169 (49.7) 6.0 493 252 (51.1) 7.0 
    Embryonal CNS  184 70 (38.0) 5.6 264 96 (36.4) 6.3 
    Other CNS tumours 316 151 (47.8) 5.8 483 227 (47.0) 7.5 
Neuroblastoma 307 154 (50.2) 1.0 372 183 (49.2) 1.3 
Nephroblastoma 226 121 (53.5) 3.0 292 158 (54.1) 3.3 
Malignant bone tumours 153 80 (52.3) 11.0 283 141 (49.8) 12.3 
Soft tissue sarcomas 272 114 (41.9) 5.6 401 176 (43.9) 7.8 
Abbreviations: HL Hodgkin lymphoma, NHL non-Hodgkin lymphoma, CNS  Central Nervous System  
22 
 
 1 
Table 2. Results of global clustering and cluster detection tests at birth or diagnosis 2 
 3 
 
k-functions  
adjusted pa 
 (d in m) 
Cuzick-Edwards’ 
adjusted pa  
(k  NN) 
Kulldorff’s scan 
adjusted pa  
(r in m) 
2nd level 
adjusted pb 
Diagnostic group Birth 
All cancersc 0.11 (100) 0.18 (3) 0.94 (137) 0.28 
Lymphoma 0.51 (3,000) 0.65 (7) 0.30 (2,209) 0.62 
    HL 0.31 (4,000) 0.51 (15) 0.73 (2,850) 0.58 
    NHL 0.77 (1,000) 0.69 (2) 0.36 (2,556) 0.66 
CNS tumours 0.44 (100) 0.81 (1) 0.45 (4,287) 0.76 
    Astrocytoma 0.58 (1,000) 0.49 (11) 0.08 (3,598) 0.20 
    Embryonal CNS  0.43 (3,000) 0.50 (15) 0.02 (66,350) 0.05 
    Other CNS tumours 0.81 (4,000) 0.73 (15) 0.24 (8,640) 0.47 
Neuroblastoma 0.62 (250) 0.76 (15) 0.47 (51,491) 0.75 
Nephroblastoma 0.11 (1,000) 0.21 (15) 0.38 (12,291) 0.23 
Malignant bone tumours 0.27 (600) 0.24 (3) 0.69 (2,620) 0.48 
Soft tissue sarcomas 0.94 (3,000) 0.46 (11) 0.54 (4,275) 0.77 
Overall pd = 0.43 
 Diagnosis 
All cancersc <0.01 (4,000) 0.08 (1) 0.17 (8,550) 0.01 
Lymphoma 0.01 (3,000) 0.56 (6) 0.44 (6,262) 0.04 
    HL 0.02 (3,000) 0.63 (2) 0.46 (4,582) 0.06 
    NHL 0.28 (600) 0.25 (4) 0.26 (577) 0.43 
CNS tumours 0.20 (4,000) 0.05 (10) 0.24 (461) 0.13 
    Astrocytoma 0.21 (5,000) 0.16 (11) 0.30 (2,066) 0.37 
    Embryonal CNS  0.03 (450) 0.01 (2) 0.05 (17,400) 0.02 
23 
 
    Other CNS tumours 0.63 (3,000) 0.12 (4) 0.10 (1,169) 0.24 
Neuroblastoma 0.08 (5,000) 0.52 (1) 0.33 (61,818) 0.19 
Nephroblastoma 0.89 (100) 0.61 (15) 0.05 (13,753) 0.13 
Malignant bone tumours 0.39 (5,000) 0.59 (15) 0.89 (1,245) 0.68 
Soft tissue sarcomas 0.82 (4,000) 0.33 (15) 0.10 (5,325) 0.24 
Overall pd = 0.13 
Abbreviations: HL Hodgkin lymphoma, NHL non-Hodgkin lymphoma, CNS  Central Nervous System, NN Nearest 1 
Neighbours  2 
 3 
a Data are p-values adjusted for the different input values d, k and r of the test (First level adjustment, 4 
see electronic supplementary material). The parameter for which the lowest p-value was found is 5 
reported in parenthesis. For Kulldorff’s cicular scan, the latter represents the radius of the most likely 6 
cluster.  7 
b P-value additionally adjusted for the different statistical tests performed in each diagnostic group.  8 
c
 Includes childhood leukaemia cases (N= 1,297 and 1,865 for birth and diagnosis, respectively) which 9 
were the subject of a separate investigation [12]. 10 
d P-value additionally adjusted for the different diagnostic groups considered including the all cancers 11 
combined group. 12 
  13 
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Figure legends 1 
Fig. 1 Flow chart of the study population  2 
Fig. 2 The difference in k-functions for residence at diagnosis for all cancers combined, lymphoma, 3 
Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. The solid line shows the observed difference of 4 
the k-functions between cases and controls, whereas the dashed line indicates the mean difference 5 
observed in Monte Carlo samples in which the cases were randomly redistributed over locations 6 
(random labelling). The shaded area illustrates the 95% simulation envelopes (under random labelling) 7 
and values within it indicate no evidence of clustering. The inset plot in the top-left plot shows the 8 
difference in k-functions zoomed in on the smallest distances.  9 
Fig. 3 The most likely cluster identified by Kulldorff’s circular scan for embryonal CNS tumours for 10 
place of residence at birth (dashed circle) and at diagnosis (solid circle). The shading shows the 11 
population density per municipality in quintiles (Q), with darker colours indicating higher population 12 
density.  13 
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Fig. 3 1 
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